Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab Intravitreal for Myopic Choroidal Neovascularization

NCT00797992 is registered in ClinicalTrials.gov with Instituto de Olhos de Goiania as lead sponsor.

NCT NCT00797992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00797992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
Lead sponsor
Instituto de Olhos de Goiania
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2007
Completion date
November 30, 2008
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopic choroidal neovascularization